Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
36
datasets available to search
ShareScore release 0.9.0
Dataset results
36 results for “mesalazine”
Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD)
ClinicalTrials.gov study NCT00300118. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis
ClinicalTrials.gov study NCT01038739. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis.
ClinicalTrials.gov study NCT00737789. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine
ClinicalTrials.gov study NCT00946946. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Chemopreventive Action of Mesalazine on Colorectal Cancer: a Pilot Study for an "in Vivo" Evaluation of the Molecular Effects on β-catenin Signaling Pathway.
ClinicalTrials.gov study NCT02077777. IPD Sharing: NO. Countries: 1. Publications: 7.
OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis
ClinicalTrials.gov study NCT00449722. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis
ClinicalTrials.gov study NCT00695643. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative Proctitis
ClinicalTrials.gov study NCT01966783. IPD Sharing: Not stated. Countries: 1. Publications: 1.
QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®)
ClinicalTrials.gov study NCT02368743. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)
ClinicalTrials.gov study NCT01316718. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis.
ClinicalTrials.gov study NCT00259571. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC)
ClinicalTrials.gov study NCT00747110. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitis
ClinicalTrials.gov study NCT00548574. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis
ClinicalTrials.gov study NCT00450086. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis
ClinicalTrials.gov study NCT01011322. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis
ClinicalTrials.gov study NCT01209208. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC)
ClinicalTrials.gov study NCT00746447. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Mesalazine Therapy in Patients With Irritable Bowel Syndrome
ClinicalTrials.gov study NCT00626288. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis
ClinicalTrials.gov study NCT00503243. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Mesalazine and/or Lactobacillus Casei in the Diverticular Disease of the Colon
ClinicalTrials.gov study NCT01534754. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.